Roche loses appeal to block market entry of rival cancer drug
A Roche subsidiary will be unable to block Amgen from producing the cancer drug Mvasi (bevacizumab), the Court of Appeals for the Federal Circuit has ruled.
EPO launches ‘Fighting coronavirus’ data platform
The European Patent Office has unveiled data sets relating to antiviral vaccines and pharmaceutical therapeutics as part of its new “Fighting coronavirus” platform.
Australian court affirms Mylan patent invalidation
The Federal Court of Australia has upheld a patent victory for Indian generic manufacturer Sun Pharma over Mylan in a dispute over cholesterol drug fenofibrate.
Federal Circuit rules CardioNet patents 'abstract ideas'
US medical technology company CardioNet has lost an appeal at the US Court of Appeals for the Federal Circuit , which found its patents covered abstract concepts and therefore are invalid.
Carpmaels & Ransford promotes Jennifer Antcliff to partner
European law firm Carpmaels & Ransford has promoted Jennifer Antcliff to partner in its dispute resolution team in its London office, bringing the total number of partners in the team to five.
Sandoz fails in Enbrel patent challenge, but Fed Circuit split
Amgen has won a key patent victory over Sandoz in a dispute over biologic Enbrel.
Glenmark becomes fifth generic to be charged with US antitrust violations
Glenmark Pharmaceuticals has been charged with conspiring to fix prices for generic drugs, according to a statement released by the US Department of Justice.
Chiesi blocks Japanese drugmaker’s new brand at EU General Court
Japan-based Nitto Pharmaceutical Industries has been blocked from using its ‘Noster’ brand in the EU, in a win for Italian drugmaker Chiesi Farmaceutici.
Labrador drops BioFire suit after COVID-19 revelation
Labrador Diagnostics has dropped its controversial patent complaint against COVID-19 test developer BioMerieux.
J&J wants $25m over ‘contaminated’ fake medical tools
Johnson & Johnson has accused a medical supplier of distributing counterfeit surgical tools that are “bacterially contaminated and critically defective”.
